NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Ambuja Cements Outlook Revised Amid Industry Growth Concerns

Choice Institutional Equities has released a report on Ambuja Cements (ACEM) with a revised outlook, citing slower industry growth and a weak pricing environment. The report projects a 5% growth in the industry for FY27E, down from previous expectations. This slower growth, combined with subdued demand, is expected to limit Ambuja Cements' ability to pass on cost pressure to consumers.

Key Challenges Ahead

The integration of Penna and Sanghi Cement is also expected to weigh on Ambuja Cements' near-term profitability and execution. Lower utilization rates and higher-than-expected maintenance capital expenditure and costs are major concerns. However, despite these challenges, Choice Institutional Equities maintains its BUY rating on ACEM.

Read also: Market Analysis: Key Stocks to Watch - Narayana Hrudayalaya, ABB India, Federal Bank, Premier Energies, Ather Energy and More

Reasons for the BUY Rating

The research firm cites several factors in support of its BUY rating. These include Ambuja Cements' capacity expansion plans, which are expected to add approximately 10 million tonnes per annum (Mtpa) of capacity in FY27E. Additionally, the company is targeting cost savings of INR 150-200 per tonne in FY27 through the use of fly ash and green energy. Furthermore, Ambuja Cements is expected to increase its premium product share, which will drive better realizations and contribute to the company's profitability.

Revised Target Price

Reflecting a more cautious outlook, Choice Institutional Equities has revised its target price for Ambuja Cements to INR 570 per share, down from its earlier target price of INR 660 per share.

Read also: FirstClub Secures $55 Million in Funding from Peak XV, Sofina, and Other Investors 9 Months After $22 Million Series A Round

CompanyTarget Price (Old)Target Price (New)
Ambuja Cements (ACEM)INR 660/shareINR 570/share

Recommendation

Choice Institutional Equities retains its BUY rating on Ambuja Cements, citing the company's capacity expansion plans, cost-saving initiatives, and increasing premium product share. However, the revised target price reflects a more cautious outlook for the company.

Investor Takeaway

Investors should be cautious with Ambuja Cements due to a weak pricing environment and integration challenges.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.